{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T17:05:11Z","timestamp":1766336711847,"version":"3.40.4"},"reference-count":250,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1988,4,1]],"date-time":"1988-04-01T00:00:00Z","timestamp":575856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Toxicology"],"published-print":{"date-parts":[[1988,4]]},"DOI":"10.1007\/bf03259936","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T10:14:51Z","timestamp":1354270491000},"page":"107-127","source":"Crossref","is-referenced-by-count":39,"title":["Adverse Reactions and Interactions of Cyclosporin"],"prefix":"10.1007","volume":"3","author":[{"given":"J. P.","family":"Scott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. W.","family":"Higenbottam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"BF03259936_CR1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF01962250","volume":"4","author":"E Abisch","year":"1986","unstructured":"Abisch E, Beveridge T, Gratwohl A, Niederberger W, Nussbaumer K, et al. Cyclosporin A: correlation between HPLC and RIA serum levels. Pharmaceutisch Weekblad Scientific Edition 4: 84\u201386, 1986","journal-title":"Pharmaceutisch Weekblad Scientific Edition"},{"key":"BF03259936_CR2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(87)90294-7","volume":"1","author":"DH Adams","year":"1987","unstructured":"Adams DH, Ponsford S, Gunson B, Boon A, Honigsberger L, et al. Neurological complications following liver transplantation. Lancet 1: 949\u2013951, 1987","journal-title":"Lancet"},{"key":"BF03259936_CR3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0140-6736(83)90345-8","volume":"2","author":"D Adu","year":"1983","unstructured":"Adu D, Turney J, Michael J, McMaster P. Hyperkalemia in cyclosporine-treated renal allograft recipients. Lancet 2: 370\u2013372, 1983","journal-title":"Lancet"},{"key":"BF03259936_CR4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00007691-198503000-00010","volume":"7","author":"RP Agarwal","year":"1985","unstructured":"Agarwal RP, McPherson RA, Threatle GA. Assessment of cyclosporin A in whole blood and plasma in five patients with different haematocrit. Therapeutic Drug Monitoring 7: 61\u201365, 1985","journal-title":"Therapeutic Drug Monitoring"},{"key":"BF03259936_CR5","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(85)90543-4","volume":"2","author":"RD Allen","year":"1985","unstructured":"Allen RD, Michie CA, Morris PJ, Chapman G. Venous thrombosis and cyclosporin. Lancet 2: 1004, 1985","journal-title":"Lancet"},{"key":"BF03259936_CR6","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/clinchem\/32.7.1407","volume":"32","author":"T Annesley","year":"1986","unstructured":"Annesley T, Matz K, Balogh L, Clayton L, Glacerio D. Liquid Chromatographie analysis of cyclosporine using a microbore column and a reduced specimen requirement. Clinical Chemistry 32: 1407\u20131409, 1986","journal-title":"Clinical Chemistry"},{"key":"BF03259936_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(85)91964-6","volume":"1","author":"R Assan","year":"1985","unstructured":"Assan R, Feutren G, Debray-Sachs M, Quiniou-Debrie MC, Laborie C, et al. Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus. Lancet 1: 67\u201371, 1985","journal-title":"Lancet"},{"key":"BF03259936_CR8","first-page":"1673","volume":"17","author":"K Atkinson","year":"1985","unstructured":"Atkinson K, Biggs J, Darveniza P, Boland J, Concannon A, et al. Spinal cord and cerebellar-like syndromes associated with the use of cyclosporine in human recipients of allogenic marrow transplants. Transplantation Proceedings 17: 1673\u20131675, 1985","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00007890-198407000-00009","volume":"38","author":"K Atkinson","year":"1984","unstructured":"Atkinson K, Biggs J, Darveniza P, Borland J, Concannon A, et al. Cyclosporine-associated central nervous system toxicity after allogeneic bone marrow transplantation. Transplantation 38: 34\u201337, 1984","journal-title":"Transplantation"},{"key":"BF03259936_CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0090-9556(25)08134-6","volume":"13","author":"WM Awni","year":"1985","unstructured":"Awni WM, Sawchuck RJ. The pharmacokinetics of cyclosporin II: blood-plasma distribution and binding studies. Drug Metabolism and Disposition 13: 127\u2013132, 1985","journal-title":"Drug Metabolism and Disposition"},{"key":"BF03259936_CR11","first-page":"1537","volume":"18","author":"JF Bach","year":"1986","unstructured":"Bach JF. Cyclosporine in type I diabetes: rationale, expected benefits and potential limitations. Transplantation Proceedings 18: 1537\u20131539, 1986","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR12","first-page":"93","volume":"41","author":"JF Bach","year":"1975","unstructured":"Bach JF. The mode of action of immunosuppressive drugs. Frontiers of Biology 41: 93\u2013225, 1975","journal-title":"Frontiers of Biology"},{"key":"BF03259936_CR13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00007890-198610000-00007","volume":"42","author":"L Backman","year":"1986","unstructured":"Backman L, Ringden O, Bjorkhem I, Lindback B. Increased serum beta 2 microglobulin during rejection, cyclosporine-induced nephrotoxicity and cytomegalovirus infection in renal transplant recipients. Transplantation 42: 368\u2013371, 1986","journal-title":"Transplantation"},{"key":"BF03259936_CR14","first-page":"641","volume":"34","author":"CS Balazs","year":"1986","unstructured":"Balazs CS, Kiss E, Fand NR. Cyclosporine A inhibits TSH receptor synthesis in vivo.Clinical Research 34: 641 A, 1986","journal-title":"Clinical Research"},{"key":"BF03259936_CR15","first-page":"1764","volume":"19","author":"EJG Barros","year":"1987","unstructured":"Barros EJG, Boim MA, Figueiredo JF, Sigulem D, Ramos OL, et al. Cyclosporin: glomerular hemodynamics. Transplantation Proceedings 19: 1764, 1987","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"BF03259936_CR16","first-page":"S62","volume":"25","author":"DC Batlle","year":"1986","unstructured":"Batlle DC, Gutterman C, Tarka J, Prasad R. Effect of short-term cyclosporine A administration on urinary acidification. Clinical Nephrology 25 (Suppl. 1): S62\u2013S69, 1986","journal-title":"Clinical Nephrology"},{"key":"BF03259936_CR17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0140-6736(87)90916-0","volume":"2","author":"RW Baumhefner","year":"1987","unstructured":"Baumhefner RW, Myers LW, Ellison GW, Tourtellote WW, Belendiuk GW, et al. Huge cyclosporin overdose with favourable outcome. Lancet 2: 332, 1987","journal-title":"Lancet"},{"key":"BF03259936_CR18","first-page":"305","volume":"37","author":"CR Baxter","year":"1982","unstructured":"Baxter CR, Duggin GG, Willis NS, Hall BM, Horvath JS, et al. Cyclosporin A-induced increases in renin storage and release. Research Communications in Chemical Pathology and Pharmacology 37: 305\u2013311, 1982","journal-title":"Research Communications in Chemical Pathology and Pharmacology"},{"key":"BF03259936_CR19","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0002-9149(85)90406-0","volume":"56","author":"M Bellet","year":"1985","unstructured":"Bellet M, Cabrol C, Sassano P, Leger P, Corvol P, et al. Systemic hypertension after cardiac transplantation: effect of cyclosporine on the renin-angiotensin-aldosterone system. American Journal of Cardiology 56: 927\u2013931, 1985","journal-title":"American Journal of Cardiology"},{"key":"BF03259936_CR20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2133.1985.tb02096.x","volume":"113","author":"PL Bencini","year":"1985","unstructured":"Bencini PL, Montagnino G, Crosti C, Sala F. Acne in a kidney transplant patient treated with cyclosporin A. British Journal of Dermatology 113: 373\u2013374, 1985","journal-title":"British Journal of Dermatology"},{"key":"BF03259936_CR21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000249288","volume":"172","author":"PL Bencini","year":"1986","unstructured":"Bencini PL, Montagnino G, Sala F, DeVecchi A, Crosti C, et al. Cutaneous lesions in 67 cyclosporin-induced renal transplant recipients. Dermatologica 172: 24\u201330, 1986","journal-title":"Dermatologica"},{"issue":"1","key":"BF03259936_CR22","first-page":"S126","volume":"25","author":"WM Bennett","year":"1986","unstructured":"Bennett WM. Comparison of cyclosporine nephrotoxicity with aminoglycoside nephrotoxicity. Clinical Nephrology 25 (Suppl. 1): S126\u2013S129, 1986","journal-title":"Clinical Nephrology"},{"key":"BF03259936_CR23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(85)92053-7","volume":"1","author":"JH Berden","year":"1985","unstructured":"Berden JH, Hoitsma AJ, Merx JL, Keyser A. Severe central nervous system toxicity associated with cyclosporin. Lancet 1: 219\u2013220, 1985","journal-title":"Lancet"},{"key":"BF03259936_CR24","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/00007890-198705000-00035","volume":"43","author":"AAM Blaauw","year":"1987","unstructured":"Blaauw AAM, Leunissen KML, Cheriex EC, Wolters J, Kootstra G, et al. Disappearance of the pulmonary capillary leak syndrome when intravenous cyclosporine is replaced by oral cyclosporine. Transplantation 43: 758\u2013759, 1987","journal-title":"Transplantation"},{"key":"BF03259936_CR25","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(86)91594-1","volume":"1","author":"B Boubigot","year":"1986","unstructured":"Boubigot B, Guiserix J, Airiau J, Bresollette L, Morin JF, et al. Nicardipine increases cyclosporin blood levels. Lancet 1: 1447, 1986","journal-title":"Lancet"},{"key":"BF03259936_CR26","first-page":"1811","volume":"19","author":"JP Boudreaux","year":"1987","unstructured":"Boudreaux JP, McHugh L, Cnaafax DM, Asher N, Sutherland DER, et al. Cyclosporine, combination immunosuppression and posttransplant diabetes mellitus. Transplantation Proceedings 19: 1811\u20131813, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0002-9343(82)90087-0","volume":"73","author":"D Brigden","year":"1982","unstructured":"Brigden D, Rosling AE, Woods NC. Renal function after acyclovir intravenous injection. American Journal of Medicine 73: 182\u2013185, 1982","journal-title":"American Journal of Medicine"},{"key":"BF03259936_CR28","first-page":"1814","volume":"19","author":"J Brunkwell","year":"1987","unstructured":"Brunkwell J, Bergqvist D, Bergentz S-E, Bornmyr S, Husberg B. Deep venous thrombosis in patients undergoing renal transplantation: effects of cyclosporine A. Transplantation Proceedings 19: 1814, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR29","first-page":"S130","volume":"25","author":"FP Brunner","year":"1986","unstructured":"Brunner FP, Hermle M, Mihasch MJ, Thiel G. Mannitol potentiates cyclosporine nephrotoxicity. Clinical Nephrology 25 (Suppl.): S130\u2013S136, 1986","journal-title":"Clinical Nephrology"},{"key":"BF03259936_CR30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/BF01982474","volume":"11","author":"E Bueding","year":"1981","unstructured":"Bueding E, Hawkins J, Cha YN. Antischistosomal effects of cyclosporin A. Agents and Actions 11: 380\u2013383, 1981","journal-title":"Agents and Actions"},{"key":"BF03259936_CR31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/eji.1830110812","volume":"8","author":"D Bunjes","year":"1981","unstructured":"Bunjes D, Hardt C, Rollinghoff M, Wagner H. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. European Journal of Immunology 8: 657\u2013661, 1981","journal-title":"European Journal of Immunology"},{"issue":"1","key":"BF03259936_CR32","first-page":"S111","volume":"25","author":"MD Burke","year":"1986","unstructured":"Burke. MD, Whiting PH. The role of drug metabolism in cyclosporine A nephrotoxicity. Clinical Nephrology 25 (Suppl. 1): S111\u2013S116, 1986","journal-title":"Clinical Nephrology"},{"key":"BF03259936_CR33","first-page":"1780","volume":"19","author":"P Chan","year":"1987","unstructured":"Chan P, Chapman JR, Morris PJ. Glycosuria: an index of cyclosporine nephrotoxicity. Transplantation Proceedings 19: 1780, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR34","first-page":"1259","volume":"312","author":"B Chapuis","year":"1985","unstructured":"Chapuis B, Helg C, Jeannet M, Zulian G, Huler P, et al. Anaphylactic reaction to intravenous cyclosporine. New England Journal of Medicine 312: 1259, 1985","journal-title":"New England Journal of Medicine"},{"key":"BF03259936_CR35","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(85)90601-4","volume":"1","author":"N Choudhury","year":"1985","unstructured":"Choudhury N, Neild GH, Brown Z, Cameron JS. Thromboembolic complications in cyclosporin-treated kidney allograft recipients. Lancet 1: 606, 1985","journal-title":"Lancet"},{"key":"BF03259936_CR36","first-page":"1804","volume":"19","author":"I Cockburn","year":"1987","unstructured":"Cockburn I. Assessment of the risks of malignancy and lymphomas developing in patients using Sandimmune. Transplantation Proceedings 19: 1804\u20131807, 1987","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"BF03259936_CR37","first-page":"50","volume":"18","author":"I Cockburn","year":"1986","unstructured":"Cockburn I. Cyclosporin A: a clinical evaluation of drug interactions. Transplantation Proceedings 18 (Suppl. 5): 50\u201355, 1986","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-101-5-667","volume":"101","author":"DJ Cohen","year":"1984","unstructured":"Cohen DJ, Loertscher R, Rubin MF, Tilney NL, Carpenter CB, et al. Cyclosporine: a new immunosuppressive agent for organ transplantation. Annals of Internal Medicine 101: 667\u2013682, 1984","journal-title":"Annals of Internal Medicine"},{"key":"BF03259936_CR39","first-page":"1829","volume":"19","author":"SL Cohen","year":"1987","unstructured":"Cohen SL, Boner G, Rosenfeld JB, Shmueli D, Sperling O, et al. The mechanism of hyperuricaemia in cyclosporine-treated renal transplant recipients. Transplantation Proceedings 19: 1829\u20131830, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.3885394","volume":"228","author":"PM Colombani","year":"1985","unstructured":"Colombani PM, Robb A, Hess AD. Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes. Science 228: 337\u2013339, 1985","journal-title":"Science"},{"issue":"1","key":"BF03259936_CR41","first-page":"2567","volume":"15","author":"DA Cooley","year":"1983","unstructured":"Cooley DA, Frazjer OH, Painvin GA, Boldt L, Kahan BD. Cardiac and cardiopulmonary transplantation for immunosuppression: recent Texas Heart Institute experience. Transplantation Proceedings 15 (4, Suppl. 1): 2567\u20132572, 1983","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-5223(19)38477-6","volume":"91","author":"JG Copeland","year":"1986","unstructured":"Copeland JG, Emery RW, Levinson MM, Icenogle TB, Riley JE, et al. Cyclosporine: an immunosuppressive panacea? Journal of Thoracic and Cardiovascular Surgery 91: 26\u201329, 1986","journal-title":"Journal of Thoracic and Cardiovascular Surgery"},{"key":"BF03259936_CR43","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00007890-198705000-00039","volume":"43","author":"L Corbone","year":"1987","unstructured":"Corbone L, Appel GB, Benvenisty AI, Cohen DJ, Kunis CL, et al. Adult respiratory distress syndrome associated with oral cyclosporine. Transplantation 43: 767\u2013769, 1987","journal-title":"Transplantation"},{"key":"BF03259936_CR44","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0140-6736(82)91366-6","volume":"2","author":"C Cunningham","year":"1982","unstructured":"Cunningham C, Burke MD, Whiting PH, Simpson JG, Wheatley DN. Ketoconazole, cyclosporin and the kidney. Lancet 2: 1464, 1982","journal-title":"Lancet"},{"key":"BF03259936_CR45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(86)90355-7","volume":"2","author":"JJ Curtis","year":"1986","unstructured":"Curtis JJ, Dubovsky E, Whelchel JD, Luke RG, Diethelm AG, et al. Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet 2: 477\u2013479, 1986","journal-title":"Lancet"},{"key":"BF03259936_CR46","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM198302173080707","volume":"308","author":"JJ Curtis","year":"1983","unstructured":"Curtis JJ, Luke RG, Whelchel JD, Diethelm AG, Jones P, et al. Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension. New England Journal of Medicine 308: 377\u2013381, 1983","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"BF03259936_CR47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0006-291X(87)91294-0","volume":"145","author":"TO Daniel","year":"1987","unstructured":"Daniel TO, Ives HE. Cyclosporin A inhibits kinase C-independent activation of the Na+\/H+ exchanger by PDGF and vanadate. Biochemical and Biophysical Research Communications 145(1): 111\u2013117, 1987","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"BF03259936_CR48","unstructured":"De Groen PC, Krom RAF. The role of cyclosporin-A and cholesterol in a new central nervous system syndrome after liver transplantation. International Organ Transplant Forum, Pittsburgh, Abstract, p. 26, 1987"},{"key":"BF03259936_CR49","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1001\/jama.1983.03340050059032","volume":"250","author":"HJ Deeg","year":"1983","unstructured":"Deeg HJ, Kennedy MS, Saunders JE, Thomas ED, Storb R. Successful pregnancy after bone marrow transplantation for severe aplastic anemia and immunosuppression by cyclosporine. Journal of the American Medical Association 250: 647, 1983","journal-title":"Journal of the American Medical Association"},{"key":"BF03259936_CR50","first-page":"830","volume":"16","author":"BH Deligny","year":"1987","unstructured":"Deligny BH, Consonne R, Ryckelynck JP, Bathos JM, Levaltier B. Acute poisoning with cyclosporin. Presse Medicale 16: 830, 1987","journal-title":"Presse Medicale"},{"key":"BF03259936_CR51","first-page":"811","volume-title":"Cyclosporine: biological activity and clinical applications","author":"E Deltz","year":"1984","unstructured":"Deltz E, Ulrichs K, Engemann R, Schack T, Friedrichs B, et al. Prevention of graft-versus-host reaction following small bowel transplantation by temporary cyclosporine treatment. In Kahan (Ed.) Cyclosporine: biological activity and clinical applications, pp. 811\u2013815, Grune & Stratton, Orlando, Florida, 1984"},{"key":"BF03259936_CR52","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(87)91988-X","volume":"1","author":"G Deray","year":"1987","unstructured":"Deray G, LeHoang P, Caboub P, Assogba U, Grippon P, et al. Oral contraceptive interaction with cyclosporin. Lancet 1: 158\u2013159, 1987","journal-title":"Lancet"},{"key":"BF03259936_CR53","first-page":"66","volume":"16","author":"H Dieperink","year":"1986","unstructured":"Dieperink H, Leyssac PP, Starklint H, Kemp E. Nephrotoxicity of cyclosporin A: a lithium clearance micropuncture study in rats. European Journal of Clinical Investigations 16: 66\u201377, 1986","journal-title":"European Journal of Clinical Investigations"},{"key":"BF03259936_CR54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/01971528108062989","volume":"2","author":"P Donatsch","year":"1981","unstructured":"Donatsch P, Abisch E, Hornberger M, Traber R, Voges R. A radioimmunoassay to measure cyclosporin A in plasma and serum samples. Journal of Immunoassay 2: 19\u201332, 1981","journal-title":"Journal of Immunoassay"},{"key":"BF03259936_CR55","first-page":"1825","volume":"19","author":"P Dorian","year":"1987","unstructured":"Dorian P, Carella C, Strauss M, David T, East S, et al. Cyclosporine nephrotoxicity and cyclosporine-digoxin interaction prior to heart transplantation. Transplantation Proceedings 19: 1825\u20131827, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR56","volume-title":"Cyclosporine: biological activity and clinical applications","author":"JS Dummer","year":"1984","unstructured":"Dummer JS, Bahnson HT, Griffith BP, Hardesty RL, Thompson ME, et al. Infections in patients on cyclosporine and prednisone following cardiac transplantation. In Kahan (Ed.) Cyclosporine: biological activity and clinical applications, Grune & Stratton Inc., Orlando, 1984"},{"key":"BF03259936_CR57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00007890-198309000-00007","volume":"36","author":"JS Dummer","year":"1983","unstructured":"Dummer JS, Hardy A, Poorsattar A, Ho Monto. Early infections in kidney, heart, and liver recipients on cyclosporine. Transplantation 36: 259\u2013267, 1983","journal-title":"Transplantation"},{"key":"BF03259936_CR58","first-page":"S14","volume":"25","author":"JI Duncan","year":"1986","unstructured":"Duncan JI, Thomson AW, Aldridge RD, Simpson JG, Whiting PH. Cyclosporine-induced renal structural damage: influence of dosage, strain, age and sex, with reference to the rat and guinea pig. Clinical Nephrology 25 (Suppl. 1): S14\u2013S17, 1986","journal-title":"Clinical Nephrology"},{"key":"BF03259936_CR59","first-page":"829","volume":"2","author":"S Durrant","year":"1985","unstructured":"Durrant S, Chipping PM, Palmer S, Gordon-Smith EC. Cyclosporin A, methylprednisolone and convulsions. Lancet 2: 829\u2013830, 1985","journal-title":"Lancet"},{"key":"BF03259936_CR60","first-page":"1787","volume":"19","author":"D Eggensperger","year":"1987","unstructured":"Eggensperger D, O\u2019Dowd G, Schweitzer S, Light J. The clinical efficacy of cytodiagnostic urinalysis in the diagnosis of acute renal allograft rejection: a clinical-pathologic correlation of 122 urine specimens. Transplantation Proceedings 19: 1787\u20131788, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR61","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0140-6736(84)91661-1","volume":"2","author":"A Farnsworth","year":"1984","unstructured":"Farnsworth A, Hall BM, Duggin GG, Horvath JS, Tiller DJ. Interstitial fibrosing renal allografts in patients treated with cyclosporine. Lancet 2: 1470\u20131471, 1984","journal-title":"Lancet"},{"key":"BF03259936_CR62","first-page":"636","volume":"15","author":"A Farnsworth","year":"1983","unstructured":"Farnsworth A, Hall BM, Kirwan P, Bishop GA, Duggin GG, et al. Pathology in renal transplant patients treated with cyclosporin A. Transplantation Proceedings 15 (Suppl. 1): 636\u2013638, 1983","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR63","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00007890-198508000-00023","volume":"40","author":"DL Faustman","year":"1985","unstructured":"Faustman DL, Hauptman V, Davie JM, Lacy PE. Increase in urinary thromboxane B2 in rats caused by cyclosporine. Transplantation 40: 214\u2013218, 1985","journal-title":"Transplantation"},{"key":"BF03259936_CR64","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/bmj.295.6593.310","volume":"295","author":"J Feehally","year":"1987","unstructured":"Feehally J, Walls J, Mistry N, Horsburgh T, Taylor J, et al. Does nifedipine ameliorate cyclosporin A nephrotoxicity? British Medical Journal 295: 310, 1987","journal-title":"British Medical Journal"},{"key":"BF03259936_CR65","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0046-8177(87)80361-1","volume":"18","author":"JJ Fenoglio","year":"1987","unstructured":"Fenoglio JJ, Marboe CC. Endomyocardial biopsy: an overview. Human Pathology 18: 609\u2013612, 1987","journal-title":"Human Pathology"},{"key":"BF03259936_CR66","first-page":"473","volume-title":"Cyclosporin: biological activity and clinical applications","author":"SM Flechner","year":"1984","unstructured":"Flechner SM, van Buren C, Kerman RH, Kahan BD. The nephrotoxicity of cyclosporine in renal transplant recipients. In Kahan (Ed.) Cyclosporin: biological activity and clinical applications, pp. 473\u2013478, Grune & Stratton, Orlando, 1984"},{"key":"BF03259936_CR67","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2125.1984.tb02560.x","volume":"18","author":"DJ Freeman","year":"1984","unstructured":"Freeman DJ, Laupacis A, Keown PA, Stiller CR, Carruthers SG. Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporine metabolites. British Journal of Clinical Pharmacology 18: 887\u2013893, 1984","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259936_CR68","first-page":"776","volume":"23","author":"DJ Freeman","year":"1987","unstructured":"Freeman DJ, Martell R, Carruthers SG, Heinrichs D, Keown PA, et al. Cyclosporin-erythromycin interaction in normal subjects. British Journal of Clinical Pharmacology 23: 776\u2013778, 1987","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259936_CR69","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0002-9343(85)90447-4","volume":"78","author":"LS Friedman","year":"1985","unstructured":"Friedman LS, Dientstag JL, Nelson PW, Russell PS, Cosini AB. Anaphylactic reaction and cardiopulmonary arrest following intravenous cyclosporine. American Journal of Medicine 78: 343\u2013345, 1985","journal-title":"American Journal of Medicine"},{"key":"BF03259936_CR70","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5694\/j.1326-5377.1987.tb120278.x","volume":"146","author":"J Gibson","year":"1987","unstructured":"Gibson J, Bleasel A, Duggin G, Joshua D, Kronberg H. Cyclosporin A-associated proteinuria. Correspondence. Medical Journal of Australia 146: 325, 328\u2013329, 1987","journal-title":"Correspondence. Medical Journal of Australia"},{"key":"BF03259936_CR71","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/bjo.69.5.320","volume":"69","author":"B Gloor","year":"1985","unstructured":"Gloor B, Grathwohl A, Hahn H, Kretschmar S, Robert Y, et al. Multiple cotton-wool-spots following bone marrow transplantation for treatment of acute lymphatic leukemia. British Journal of Ophthalmology 69: 320\u2013322, 1985","journal-title":"British Journal of Ophthalmology"},{"key":"BF03259936_CR72","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.HYP.9.6_Pt_2.III96","volume":"9","author":"MS Golub","year":"1987","unstructured":"Golub MS, Berger ME. Direct augmentation by cyclosporin A of the vascular contractile response to nerve stimulation. Hypertension 9 (6, pt 2 Suppl.): 96\u2013100, 1987","journal-title":"Hypertension"},{"key":"BF03259936_CR73","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1084\/jem.163.4.922","volume":"163","author":"A Granelli-Piperno","year":"1987","unstructured":"Granelli-Piperno A, Andrus L, Steinman RM. Lymphokine and nonlymphokine mRNA levels in stimulated human T cells: kinetics, mitogen requirements and effects of cyclosporin A. Journal of Experimental Medicine 163: 922\u2013937, 1987","journal-title":"Journal of Experimental Medicine"},{"key":"BF03259936_CR74","first-page":"404","volume":"38","author":"A Gratwohl","year":"1986","unstructured":"Gratwohl A, Speck B. Bone marrow transplantation with ciclosporin. Progress in Allergy 38: 404\u2013431, 1986","journal-title":"Progress in Allergy"},{"issue":"5","key":"BF03259936_CR75","first-page":"9","volume":"18","author":"J Grevel","year":"1986","unstructured":"Grevel J. Absorption of cyclosporine A after oral dosing. Transplantation Proceedings 18 (Suppl. 5): 9\u201315, 1986","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR76","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(86)91699-5","volume":"1","author":"JM Grino","year":"1986","unstructured":"Grino JM, Sabate I, Castelao AM, Alsina J. Influence of diltiazem on cyclosporin clearance. Lancet 1: 1387, 1986","journal-title":"Lancet"},{"key":"BF03259936_CR77","first-page":"1815","volume":"19","author":"SA Gruber","year":"1987","unstructured":"Gruber SA, Pescovitz M, Simmons RL, Najarian JS, Ascher NL, et al. Thrombotic complications after renal transplantation: results from the randomised trial of cyclosporine vs azathioprine-antilymphocyte globulin. Transplantation Proceedings 19: 1815\u20131816, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR78","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2141.1986.tb02916.x","volume":"62","author":"HW Habboush","year":"1986","unstructured":"Habboush HW, Hann IM. Anaphylactic reaction to cyclosporin in a bone marrow transplant recipient. British Journal of Haematology 62: 195\u2013199, 1986","journal-title":"British Journal of Haematology"},{"key":"BF03259936_CR79","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF00453499","volume":"29","author":"H-J Hahn","year":"1986","unstructured":"Hahn H-J, Dunger A, Laube F, Besch W, Radloff E, et al. Reversibility of the acute toxic effect of cyclosporin A on pancreatic B cells of Wistar rats. Diabetologia 29: 489\u2013494, 1986","journal-title":"Diabetologia"},{"key":"BF03259936_CR80","first-page":"400","volume":"18","author":"DV Hamilton","year":"1981","unstructured":"Hamilton DV, Evans DB, Henderson RG, Thiru S, Calne RY, et al. \u201cNephrotoxicity\u201d and metabolic acidosis in transplant patients on cyclosporin A. Proceedings of the European Dialysis and Transplantation Association 18: 400\u2013407, 1981","journal-title":"Proceedings of the European Dialysis and Transplantation Association"},{"key":"BF03259936_CR81","first-page":"393","volume-title":"Cambridge","author":"DV Hamilton","year":"1982","unstructured":"Hamilton DV, Evans DB, Thiru S. In White DJ (Ed.) Cyclosporin: proceedings of an international symposium, Cambridge, pp. 393\u2013411, Elsevier Biomedical Publishers, Amsterdam, 1982"},{"key":"BF03259936_CR82","first-page":"144","volume":"22","author":"DJ Handelsman","year":"1984","unstructured":"Handelsman DJ, McDowell IFW, Caterson D, Tiller DJ, Hall BM, et al. Testicular function after renal transplantation: comparison of cyclosporin A with azathioprine and prednisolone combination regimes. Clinical Nephrology 22: 144\u2013148, 1984","journal-title":"Clinical Nephrology"},{"key":"BF03259936_CR83","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.6238408","volume":"226","author":"RE Handschumacher","year":"1984","unstructured":"Handschumacher RE, Harding MW, Rice J, Drugge DW. Cytophilin: a specific cytosolic binding protein for cyclosporin A. Science 226: 544\u2013547, 1984","journal-title":"Science"},{"key":"BF03259936_CR84","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/bmj.292.6512.16","volume":"292","author":"KP Harris","year":"1986","unstructured":"Harris KP, Russell GI, Parvin SD, Veitch PS, Walls J. Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients. British Medical Journal 292: 16, 1986","journal-title":"British Medical Journal"},{"key":"BF03259936_CR85","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/0002-9149(87)90889-7","volume":"59","author":"A Hastillo","year":"1987","unstructured":"Hastillo A, Thompson JA, Lower RR, Szentpetery S, Hess ML. Cyclosporine-induced pericardial effusion after cardiac transplantation. American Journal of Cardiology 59: 1220\u20131222, 1987","journal-title":"American Journal of Cardiology"},{"key":"BF03259936_CR86","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2141.1983.tb02068.x","volume":"54","author":"JM Haws","year":"1983","unstructured":"Haws JM. Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A. British Journal of Haematology 54: 69\u201378, 1983","journal-title":"British Journal of Haematology"},{"key":"BF03259936_CR87","first-page":"342","volume":"27","author":"JH Helderman","year":"1985","unstructured":"Helderman JH, Sagalowsky A, Dawidson I, Emerson W, Hull A, et al. CyA rescue: salvage of renal transplants under-going acute rejection unresponsive to conventional treatment. Abstract. Kidney International 27: 342, 1985","journal-title":"Abstract. Kidney International"},{"key":"BF03259936_CR88","first-page":"1419","volume":"17","author":"AD Hess","year":"1985","unstructured":"Hess AD, Colombani PM, Donnenberg AD, Fischer AC, Ryffel B. Binding of dansylated cyclosporine discriminates functional T lymphocyte subsets. Transplantation Proceedings 17: 1419\u20131421, 1985","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR89","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/019262338601400105","volume":"14","author":"GS Hill","year":"1986","unstructured":"Hill GS. Drug-induced glomerulonephropathies. Toxicology and Pathology 14: 37\u201344, 1986","journal-title":"Toxicology and Pathology"},{"key":"BF03259936_CR90","first-page":"1387","volume":"19","author":"S Hirsch","year":"1987","unstructured":"Hirsch S, Besarab A, Jorrell BE, Carabasi RA, Cressman MD, et al. Acute nephrotoxicity following intravenous cyclosporine. Transplantation Proceedings 19 (1, pt 2): 1387\u20131390, 1987","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"BF03259936_CR91","first-page":"101","volume":"18","author":"DW Holt","year":"1986","unstructured":"Holt DW, Marsden JJ, Johnston A. Measurement of cyclosporin: methodological problems. Transplantation Proceedings 18 (Suppl. 5): 101\u2013110, 1986","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR92","first-page":"2723","volume":"17","author":"M Houmant","year":"1985","unstructured":"Houmant M, LeBigot JF, Vernillet L, Sagniez G, Remi JP. Coad-ministration of erythromycin results in an increase of blood cyclosporine to toxic levels. Transplantation Proceedings 17: 2723\u20132727, 1985","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR93","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/106002808501900603","volume":"19","author":"DL Howrie","year":"1985","unstructured":"Howrie DL, Ptachinski RJ, Griffith BP, Hardesty RJ, Rosenthal JT, et al. Anaphylactoid reactions associated with parenteral cyclosporine use: possible role of cremophor EL. Drug Intelligence and Clinical Pharmacology 19: 425\u2013427, 1985","journal-title":"Drug Intelligence and Clinical Pharmacology"},{"issue":"4","key":"BF03259936_CR94","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00007890-198204000-00008","volume":"33","author":"JM Hows","year":"1982","unstructured":"Hows JM, Palmer S, Gordon-Smith EC. Use of cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anaemia. Transplantation 33(4): 382\u2013386, 1982","journal-title":"Transplantation"},{"key":"BF03259936_CR95","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00007691-198606000-00013","volume":"8","author":"A Johnston","year":"1986","unstructured":"Johnston A, Marsden JT, Holt DW. The UK cyclosporin quality assessment scheme. Therapeutic Drug Monitoring 8: 200\u2013204, 1986","journal-title":"Therapeutic Drug Monitoring"},{"key":"BF03259936_CR96","first-page":"1742","volume":"19","author":"D Jorkasky","year":"1987","unstructured":"Jorkasky D, Audet P, Williams S, Grossman R, Conrad M. Cyclosporine-induced nephrotoxicity: role of prostaglandins. Transplantation Proceedings 19: 1742\u20131744, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR97","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(82)92171-7","volume":"1","author":"DV Joss","year":"1982","unstructured":"Joss DV, Barett AJ, Kendra JR, Lucas CF, Desai S. Hypertension and convulsions in children receiving cyclosporin A. Lancet 1: 906, 1982","journal-title":"Lancet"},{"key":"BF03259936_CR98","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00007890-198506000-00009","volume":"39","author":"CH June","year":"1985","unstructured":"June CH, Thompson CB, Kennedy MS, Ninis J, Donnall Thomas E. Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation. Transplantation 39: 620\u2013624, 1985","journal-title":"Transplantation"},{"key":"BF03259936_CR99","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000184070","volume":"45","author":"K Jung","year":"1987","unstructured":"Jung K, Reinholdt C, Scolz D. Inhibited efficiency of kidney mitochondria isolated from rats treated with cyclosporin A. Nephron 45: 43\u201345, 1987","journal-title":"Nephron"},{"key":"BF03259936_CR100","volume-title":"Cyclosporin A","author":"BD Kahan","year":"1982","unstructured":"Kahan BD, Kerman RH, Agostino G, Friedman A, LeGrue SJ. The action of cyclosporine on human lymphocytes. In White (Ed.) Cyclosporin A, Elsevier Biomedical Press, Amsterdam, 1982"},{"issue":"2","key":"BF03259936_CR101","first-page":"35","volume":"17","author":"BD Kahan","year":"1985","unstructured":"Kahan BD, Van Buren CT, Lorber MI, Fletchner SM, Wideman CA, et al. Optimisation of cyclosporine immunosuppression for renal transplantation. Transplantation Proceedings 17 (Suppl. 2): 35\u201343, 1985","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR102","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/00007890-198705000-00040","volume":"43","author":"MB Katiriji","year":"1987","unstructured":"Katiriji MB. Visual hallucinations and cyclosporine. Transplantation 43: 768\u2013769, 1987","journal-title":"Transplantation"},{"key":"BF03259936_CR103","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00007890-198303000-00005","volume":"35","author":"MS Kennedy","year":"1983","unstructured":"Kennedy MS, Deeg HJ, Siegel M, Crowley JJ, Storb R, et al. Acute renal toxicity with combined use of amphotericin B and cyclosporin after marrow transplantation. Transplantation 35: 211\u2013215, 1983","journal-title":"Transplantation"},{"key":"BF03259936_CR104","unstructured":"Kennedy MS, Yee GC, Deeg HJ, Storb R, Thomas ED. Pharmacokinetics and toxicity of cyclosporine in marrow transplant patients. In Kahan (Ed.) Cyclosporine: biological activity and clinical implications, pp. 200\u2013203, Grune & Stratton, Orlando, 1984"},{"key":"BF03259936_CR105","first-page":"304","volume":"38","author":"PA Keown","year":"1984","unstructured":"Keown PA, Laupacis A, Carruthers G, Stawecki M, Koegler J, et al. Interaction between phenytoin and cyclosporine following organ transplantation. Transplantation 38: 304\u2013306, 1984","journal-title":"Transplantation"},{"key":"BF03259936_CR106","first-page":"1749","volume":"19","author":"TL Kho","year":"1987","unstructured":"Kho TL, Leunissen KML, Heidendal GAK, Ljinen PJ, Amery AK, et al. Nephrotoxic effect of cyclosporine A can be reversed by dopamine. Transplantation Proceedings 19: 1749\u20131753, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR107","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(84)92239-6","volume":"1","author":"G Klintmalm","year":"1984","unstructured":"Klintmalm G, Sawe J. High dose methylprednisolone increases plasma cyclosporin levels in renal transplant recipients. Lancet 1: 731, 1984","journal-title":"Lancet"},{"key":"BF03259936_CR108","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00007890-198502000-00005","volume":"39","author":"G Klintmalm","year":"1985","unstructured":"Klintmalm G, Sawe J, Ringden O, Van Bahr C, Magnusson A. Cyclosporine plasma levels in renal transplant patients. Transplantation 39: 132\u2013137, 1985","journal-title":"Transplantation"},{"key":"BF03259936_CR109","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00007890-198408000-00026","volume":"38","author":"G Klintmalm","year":"1984","unstructured":"Klintmalm G, Althorff P, Appleby G, Serbrardt E. Renal function in a new born baby delivered of a renal transplant patient taking cyclosporine. Transplantation 38: 198\u2013199, 1984","journal-title":"Transplantation"},{"key":"BF03259936_CR110","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/BF01739677","volume":"63","author":"P Kloke","year":"1985","unstructured":"Kloke P, Osieka R. Interaction of cyclosporin A with antineoplastic agents. Klinische Wochenschrifte 63: 1081\u20131082, 1985","journal-title":"Klinische Wochenschrifte"},{"key":"BF03259936_CR111","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF00607585","volume":"32","author":"C Kreftjais","year":"1987","unstructured":"Kreftjais C, Bilaud EM, Gaudny C, Bedrossian J. Effect of josamycin on plasma cyclosporine levels. European Journal of Pharmacology 32: 327\u2013328, 1987","journal-title":"European Journal of Pharmacology"},{"key":"BF03259936_CR112","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.0954-6820.1986.tb02749.x","volume":"220","author":"J Kventny","year":"1986","unstructured":"Kventny J, Frondsen NE, Johnsen T, Diepernick H, Mogensen E. Treatment of Grave\u2019s ophthalmopathy with cyclosporin A. Acta Medica Scandinavica 220: 189\u2013191, 1986","journal-title":"Acta Medica Scandinavica"},{"key":"BF03259936_CR113","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/0024-3205(87)90080-4","volume":"40","author":"FS Lamb","year":"1987","unstructured":"Lamb FS, Webb RC. Cyclosporine augments reactivity of isolated blood vessels. Life Sciences 40: 2571\u20132578, 1987","journal-title":"Life Sciences"},{"key":"BF03259936_CR114","first-page":"1817","volume":"19","author":"J Landmann","year":"1987","unstructured":"Landmann J, Mihatsch MJ, Ratschek M, Thiel G. Cyclosporine A and intravascular coagulation. Transplantation Proceedings 19: 1817\u20131819, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR115","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(83)91174-1","volume":"2","author":"F Langhoff","year":"1983","unstructured":"Langhoff F, Madsen S. Rapid metabolism of cyclosporin and prednisone in kidney transplant patients on tuberculostatic treatment. Lancet 2: 1303, 1983","journal-title":"Lancet"},{"key":"BF03259936_CR116","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4049\/jimmunol.131.2.712","volume":"131","author":"SJ LeGrue","year":"1983","unstructured":"LeGrue SJ, Friedman AW, Kahan BD. Binding of cyclosporine by human lymphocytes and phospholipid vesicles. Journal of Immunology 131: 712\u2013718, 1983","journal-title":"Journal of Immunology"},{"key":"BF03259936_CR117","first-page":"1989","volume":"109","author":"G Leimenstoll","year":"1984","unstructured":"Leimenstoll G, Jessen P, Zabel P, Niedermayer W. Arzneimit-telschdigung der Leber bei Kombination von Cyclosporin A einem Antikonzeptivum. Deutsche Medinizische Wochenschrift 109: 1989\u20131990, 1984","journal-title":"Deutsche Medinizische Wochenschrift"},{"key":"BF03259936_CR118","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0140-6736(82)92480-1","volume":"1","author":"C Leithner","year":"1982","unstructured":"Leithner C, Sinzinger H, Pohanka E, Schwarz M, Kretschmer G, et al. Recurrent haemolytic uremic syndrome triggered by cyclosporin A after renal transplantation. Lancet 1: 1470, 1982","journal-title":"Lancet"},{"key":"BF03259936_CR119","first-page":"344","volume":"27","author":"P Lele","year":"1985","unstructured":"Lele P, Peterson P, Young S, Jarell B, Burke JF. Cyclosporin and Tegretol \u2014 another drug interaction. Abstract. Kidney International 27: 344, 1985","journal-title":"Abstract. Kidney International"},{"key":"BF03259936_CR120","first-page":"701","volume":"1","author":"KM Leunissen","year":"1984","unstructured":"Leunissen KM, Bosman F, Van Hooff JP. Cyclosporin, uric acid and the kidney. Lancet 1: 701\u2013702, 1984","journal-title":"Lancet"},{"key":"BF03259936_CR121","first-page":"1822","volume":"19","author":"KML Leunissen","year":"1987","unstructured":"Leunissen KML, Teule J, Degenaar CP, Kho TL, Frenken LAM, et al. Impairment of liver synthetic function and decreased liver flow during cyclosporine A therapy. Transplantation Proceedings 19: 1822\u20131824, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR122","first-page":"637","volume":"1","author":"KML Leunissen","year":"1985","unstructured":"Leunissen KML, Waterval PWG, Van Hooff JP. Anaphylactic reaction to intravenous cyclosporin. Lancet 1: 637, 1985","journal-title":"Lancet"},{"key":"BF03259936_CR123","first-page":"1543","volume":"16","author":"C Levy-Marchal","year":"1986","unstructured":"Levy-Marchal C, Czernichow P. Effect of different dosages of cyclosporine A (CsA) on the early phase of overt insulin-dependent diabetes mellitus in children. Transplantation Proceedings 16: 1543\u20131544, 1986","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR124","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/bmj.286.6365.603","volume":"286","author":"GJ Lewis","year":"1983","unstructured":"Lewis GJ, Lamont CAR, Lee HA, Slapak KM. Successful pregnancy in a renal transplant recipient taking cyclosporin A. British Medical Journal 286: 603, 1983","journal-title":"British Medical Journal"},{"key":"BF03259936_CR125","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0140-6736(87)92710-3","volume":"1","author":"A Linchholm","year":"1987","unstructured":"Linchholm A, Henricsson S. Verapamil inhibits cyclosporin metabolism. Lancet 1: 1262, 1987","journal-title":"Lancet"},{"key":"BF03259936_CR126","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF01975877","volume":"42","author":"T Liu","year":"1986","unstructured":"Liu T, Cavallini M, Halberg F, Cornelissen G, Field J, et al. More on the need for circaseptan and circannual optimisation of cyclosporine therapy. Experientia 42: 20\u201322, 1986","journal-title":"Experientia"},{"key":"BF03259936_CR127","first-page":"1808","volume":"19","author":"MI Lorber","year":"1987","unstructured":"Lorber MI, van Buren CT, Rechner SM, Williams C, Kahan BD. Hepatobiliary complications of cyclosporine therapy following renal transplantation. Transplantation Proceedings 19: 1808\u20131810, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR128","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2141.1985.tb07342.x","volume":"59","author":"TP Loughran","year":"1985","unstructured":"Loughran TP, Deeg HJ, Dahlberg S, Kennedy MS, Storb R, et al. Incidence of hypertension after marrow transplantation among 112 patients randomised to either cyclosporine or methotrexate as graft-vs-host disease prophylaxis. British Journal of Haematology 59: 547\u2013553, 1985","journal-title":"British Journal of Haematology"},{"key":"BF03259936_CR129","first-page":"1262","volume":"19","author":"S Lustig","year":"1987","unstructured":"Lustig S, Stern N, Lee DBN, Berger ME, Eggena P, et al. Mechanisms of cyclosporine A hypertension. Transplantation Proceedings 19: 1262\u20131264, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR130","first-page":"443","volume":"42","author":"SC Magalini","year":"1986","unstructured":"Magalini SC, Nanni G, Agnes S, Citterio F, Castagneto M. Anaphylactic reaction to first exposure to cyclosporine. Transplantation 42: 443\u2013444, 1986","journal-title":"Transplantation"},{"key":"BF03259936_CR131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0041-008X(85)90279-0","volume":"77","author":"G Magnus","year":"1985","unstructured":"Magnus G, Cavallini M, Halberg F, Cornelissen G, Sutherland DER, et al. Circadian toxicology of cyclosporin. Toxicology and Applied Pharmacology 77: 181\u2013185, 1985","journal-title":"Toxicology and Applied Pharmacology"},{"key":"BF03259936_CR132","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/clinchem\/33.8.1493","volume":"33","author":"S Maguire","year":"1987","unstructured":"Maguire S, Kyne F, UaConaill D. Specimen collection in plastic containers gives rise to interference in liquid-chromatographic assay of cyclosporine. Clinical Chemistry 33: 1493\u20131494, 1987","journal-title":"Clinical Chemistry"},{"issue":"29","key":"BF03259936_CR133","first-page":"962","volume":"116","author":"UA Marbet","year":"1986","unstructured":"Marbet UA, Gyr K, Stadler GA. Cyclosporin in Crohn\u2019s disease: initial findings. Schweizerische Medizinische Wochenschrift 116(29): 962\u2013963, 1986","journal-title":"Schweizerische Medizinische Wochenschrift"},{"key":"BF03259936_CR134","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00007890-198508000-00022","volume":"40","author":"RJ Mason","year":"1985","unstructured":"Mason RJ, Thomson AW, Whiting PH, Gray ES, Brown PAJ, et al. Cyclosporin-induced fetotoxicity in the rat. Transplantation 40: 214\u2013216, 1985","journal-title":"Transplantation"},{"issue":"5","key":"BF03259936_CR135","first-page":"25","volume":"18","author":"G Mauer","year":"1986","unstructured":"Mauer G, Lemaire M. Biotransformation and distribution of cyclosporine and its metabolites. Transplantation Proceedings 18 (6, Suppl. 5): 25\u201334, 1986","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR136","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF01974944","volume":"21","author":"FT McAuley","year":"1987","unstructured":"McAuley FT, Simpson JG, Thomson AW, Whiting PH. Cyclosporin A-induced nephrotoxicity in the rat: relationship to increased plasma renin activity. Agents and Actions 21: 209\u2013216, 1987a","journal-title":"Agents and Actions"},{"key":"BF03259936_CR137","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0006-2952(87)90721-0","volume":"36","author":"FT McAuley","year":"1987","unstructured":"McAuley FT, Whiting PH, Thompson AW, Simpson JG. The influence of enalapril or spironolactone on experimental cyclosporin nephrotoxicity. Bichemical Pharmacology 36: 699\u2013703, 1987b","journal-title":"Bichemical Pharmacology"},{"key":"BF03259936_CR138","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00007890-198605000-00012","volume":"41","author":"RE McCabe","year":"1986","unstructured":"McCabe RE, Luft BJ, Remington JS. The effects of cyclosporine on toxoplasma gondii in vivoand in vitro.Transplantation 41: 611\u2013615, 1986","journal-title":"Transplantation"},{"key":"BF03259936_CR139","first-page":"346","volume":"38","author":"CGA McGregor","year":"1986","unstructured":"McGregor CGA, Oyer PE, Shumway NE. Heart and heart-lung transplantation. Progress in Allergy 38: 346\u2013365, 1986","journal-title":"Progress in Allergy"},{"key":"BF03259936_CR140","first-page":"1162","volume":"1","author":"MJ Mihatsch","year":"1982","unstructured":"Mihatsch MJ, Olivieri V, Marbet U, Thiel G, Harder F. Giant mitochondria in renal tubular cells and cyclosporin A. Lancet 1: 1162, 1982","journal-title":"Lancet"},{"issue":"1","key":"BF03259936_CR141","first-page":"101","volume":"17","author":"MJ Mihatsch","year":"1985","unstructured":"Mihatsch MJ, Thiel C, Basier V, Ryffel B, Landmann J, et al. Morphological patterns in cyclosporine-treated renal transplant recipients. Transplantation Proceedings 17 (Suppl. 1): 101\u2013116, 1985","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR142","first-page":"2821","volume":"15","author":"MJ Mihatsch","year":"1983","unstructured":"Mihatsch MJ, Thiel G, Spichtin HP, Oberholzer M, Brunner FP, et al. Morphological findings in kidney transplants after treatment with cyclosporine. Transplantation Proceedings 15: 2821\u20132835, 1983","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR143","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00007890-198503000-00022","volume":"39","author":"DL Modry","year":"1985","unstructured":"Modry DL, Stinson EB, Oyer PE, Jamieson SW, Baldwin JC, et al. Acute rejection and massive cyclosporine requirements in heart transplant recipients treated with rifampicin. Transplantation 39: 313\u2013314, 1985","journal-title":"Transplantation"},{"key":"BF03259936_CR144","first-page":"1416","volume":"313","author":"BVB Moller","year":"1985","unstructured":"Moller BVB, Eklund B. Toxicity of cyclosporine during treatment with androgens. New England Journal of Medicine 313: 1416, 1985","journal-title":"New England Journal of Medicine"},{"key":"BF03259936_CR145","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(82)91544-6","volume":"2","author":"GR Morgenstern","year":"1982","unstructured":"Morgenstern GR, Powles RL, Robinson B, McElwain TJ. Cyclosporine interaction with ketoconazole and melphalan. Lancet 2: 1342, 1982","journal-title":"Lancet"},{"key":"BF03259936_CR146","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.1073\/pnas.82.23.8222","volume":"82","author":"NG Moss","year":"1985","unstructured":"Moss NG, Powell SL, Falk RJ. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proceedings of the National Academy of Sciences 82: 8222\u20138226, 1985","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"BF03259936_CR147","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/bjo.71.5.387","volume":"71","author":"AU Muftuoglu","year":"1987","unstructured":"Muftuoglu AU, Pazarli H, Yurdakul S, Yazici H, Ulku BY, et al. Short term cyclosporin A treatment of Beh\u00e7ets disease. British Journal of Ophthalmology 71: 387\u2013390, 1987","journal-title":"British Journal of Ophthalmology"},{"issue":"1","key":"BF03259936_CR148","first-page":"S37","volume":"25","author":"BM Murray","year":"1986","unstructured":"Murray BM, Palier MS. Beneficial effects of renal denervation and prazosin on renal blood flow after cyclosporine in rats. Clinical Nephrology 25 (Suppl. 1): S37\u2013S39, 1986","journal-title":"Clinical Nephrology"},{"key":"BF03259936_CR149","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198409133111103","volume":"311","author":"BD Myers","year":"1984","unstructured":"Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. New England Journal of Medicine 311: 699\u2013705, 1984","journal-title":"New England Journal of Medicine"},{"key":"BF03259936_CR150","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/ajcp\/84.4.555","volume":"84","author":"JL Myles","year":"1985","unstructured":"Myles JL, Ratliff NB, McMahon JT. Interstitial accumulation of 8-10-nanometer filaments in cyclosporin treated cardiac transplant patients. American Journal of Clinical Pathology 84: 555\u2013556, 1985","journal-title":"American Journal of Clinical Pathology"},{"key":"BF03259936_CR151","first-page":"346","volume":"25","author":"KA Nath","year":"1984","unstructured":"Nath KA, Antle JP, Ferris TF. Effect of cyclosporine A on the renin-angiotensin system and potassium excretion in renal transplant patients. Kidney International 25: 346, 1984","journal-title":"Kidney International"},{"key":"BF03259936_CR152","first-page":"731","volume":"65","author":"GH Neild","year":"1984","unstructured":"Neild GH, Fan TP-D, Lewis GP. Severe systemic vascular necrosis in cyclosporin-treated rabbits with acute serum sickness. British Journal of Experimental Pathology 65: 731\u2013743, 1984","journal-title":"British Journal of Experimental Pathology"},{"key":"BF03259936_CR153","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0090-6980(85)90004-8","volume":"30","author":"GH Neild","year":"1985","unstructured":"Neild GH, Fan TP-D, Lewis GP. Severe systemic vascular necrosis in cyclosporin-treated rabbits with acute serum sickness. Prostaglandins 30: 735\u2013740, 1985","journal-title":"Prostaglandins"},{"issue":"1","key":"BF03259936_CR154","first-page":"2398","volume":"15","author":"GH Neild","year":"1983","unstructured":"Neild GH, Rocchi G, Imberti L, Fumagalli F, Brown Z, et al. Effect of cyclosporine on prostacyclin synthesis by vascular tissue in rabbits. Transplantation Proceedings 15 (Suppl. 1): 2398\u20132400, 1983","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR155","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(86)90254-0","volume":"2","author":"J Nemunaitis","year":"1986","unstructured":"Nemunaitis J, Deeg HJ, Yee GC. High cyclosporin levels after bone marrow transplantation associated with hypertriglyceridaemia. Lancet 2: 744\u2013745, 1986","journal-title":"Lancet"},{"key":"BF03259936_CR156","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1464-5491.1985.tb00679.x","volume":"2","author":"J Nerup","year":"1985","unstructured":"Nerup J, Bendtzen K, Mandrup-Poulsen T. A role for cyclosporin A in the treatment of insulin-dependent diabetes mellitus? Diabetic Medicine 2: 441\u2013446, 1985","journal-title":"Diabetic Medicine"},{"key":"BF03259936_CR157","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(86)90398-3","volume":"2","author":"HH Neumayer","year":"1986","unstructured":"Neumayer HH, Wagner K. Diltiazem and the economic use of cyclosporin. Lancet 2: 523, 1986","journal-title":"Lancet"},{"key":"BF03259936_CR158","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1128\/IAI.37.3.1093-1100.1982","volume":"37","author":"SP Nickell","year":"1982","unstructured":"Nickell SP, Scheibel LCD, Cole GA. Inhibition of rodent malaria in vivoand human malaria in vitro.Infection and Immunity 37: 1093\u20131100, 1982","journal-title":"Infection and Immunity"},{"key":"BF03259936_CR159","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archneur.1984.04050150111026","volume":"41","author":"RB Noll","year":"1984","unstructured":"Noll RB, Kulkarni R. Complex visual hallucinations and cyclosporine. Archives of Neurology 41: 329\u2013330, 1984","journal-title":"Archives of Neurology"},{"key":"BF03259936_CR160","first-page":"47","volume":"18","author":"B Odlin","year":"1986","unstructured":"Odlin B, Lindberg A. Tufreson G, Lindstrom B, Frolin L, et al. Longitudinal study of the pharmacokinetics of cyclosporine before and after renal transplantation. Transplantation Proceedings 18: 47\u201352, 1986","journal-title":"Longitudinal study of the pharmacokinetics of cyclosporine before and after renal transplantation. Transplantation Proceedings"},{"issue":"1","key":"BF03259936_CR161","first-page":"2081","volume":"19","author":"S Ohishima","year":"1987","unstructured":"Ohishima S, Fujita T, Asano H, Ono Y. The effect of cyclosporine on the early postoperative function of allografted kidneys with warm ischemic damage. Transplantation Proceedings 19(1): 2081\u20132084, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR162","first-page":"2546","volume":"15","author":"PE Oyer","year":"1983","unstructured":"Oyer PE, Stinson EB, Jamieson SW, Hunt SA, Perlroth M, et al. Cyclosporine in cardiac transplantation: a 2 1\/2 year followup. Transplantation Proceedings 15 (4, Suppl. 1): 2546\u20132552, 1983","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR163","first-page":"346","volume":"27","author":"MS Palier","year":"1987","unstructured":"Palier MS, Murray BM, Ferris TF. Decreased blood flow after cyclosporine infusion. Abstract. Kidney International 27: 346, 1987","journal-title":"Abstract. Kidney International"},{"key":"BF03259936_CR164","first-page":"155","volume":"17","author":"MS Palier","year":"1985","unstructured":"Palier MS, Murray BM. Renal dysfunction in animal models of cyclosporine toxicity. Transplantation Proceedings 17 (4, Suppl. 1): 155\u2013159, 1985","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR165","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/1523-1747.ep12470453","volume":"88","author":"SL Pardue","year":"1987","unstructured":"Pardue SL, Fite KV, Bengstan L, Lamont SJ, Boyle ML, et al. Enhanced integumental and ocular amelanosis following the termination of cyclosporine administration. Journal of Investigative Dermatology 88: 758\u2013761, 1987","journal-title":"Journal of Investigative Dermatology"},{"key":"BF03259936_CR166","first-page":"2044","volume":"17","author":"SD Parvin","year":"1987","unstructured":"Parvin SD, Veitch PS, Bell PR, Rees Y. Cyclosporin A toxicity differentiated from rejection by objective measurement of renal size by ultrasound. Transplantation Proceedings 17: 2044, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR167","first-page":"2211","volume":"19","author":"I Penn","year":"1987","unstructured":"Penn I. Cancers following cyclosporine therapy. Transplantation Proceedings 19: 2211\u20132213, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR168","first-page":"F581","volume":"251","author":"N Perico","year":"1986","unstructured":"Perico N, Benigni A, Zoja C, Delaini F, Remuzzi G. Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin A. American Journal of Physiology 251(4, pt 2): F581\u2013F587, 1986","journal-title":"American Journal of Physiology"},{"key":"BF03259936_CR169","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-2008-1050344","volume":"190","author":"LE Pilluanat","year":"1987","unstructured":"Pilluanat LE, Schmeiser T, Greber H. Toxische Retinopathie unter Cyclosporin A-therapie. Klinische Monatsblatter f\u00fcr Augenheilkunde 190: 131\u2013134, 1987","journal-title":"Klinische Monatsblatter f\u00fcr Augenheilkunde"},{"key":"BF03259936_CR170","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(86)91086-X","volume":"1","author":"JM Pochet","year":"1986","unstructured":"Pochet JM, Pirson Y. Cyclosporin-diltiazem interaction. Lancet 1: 979, 1986","journal-title":"Lancet"},{"key":"BF03259936_CR171","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00007890-198410000-00005","volume":"38","author":"PR Powell-Jackson","year":"1984","unstructured":"Powell-Jackson PR, Carmichael FJC, Calne RY, Williams SR. Adult respiratory distress syndrome and convulsions associated with the administration of cyclosporine in liver transplant recipients. Transplantation 38: 341\u2013343, 1984","journal-title":"Transplantation"},{"key":"BF03259936_CR172","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(83)91793-2","volume":"1","author":"RL Powles","year":"1983","unstructured":"Powles RL, Kay NEM, McElwain TJ, Clink HM, Dady PJ, et al. Mismatched family donors for bone marrow transplantation as treatment for acute leukemia. Lancet 1: 612\u2013615, 1983","journal-title":"Lancet"},{"key":"BF03259936_CR173","first-page":"636","volume":"1","author":"RJ Ptachinski","year":"1985","unstructured":"Ptachinski RJ, Gray J, Venkataramanan R, Van Thiel DH, Rosenthal JT. Anaphylactoid reaction to intravenous cyclosporine. Lancet 1: 636\u2013637, 1985","journal-title":"Lancet"},{"key":"BF03259936_CR174","first-page":"1728","volume":"19","author":"RJ Ptachinski","year":"1987","unstructured":"Ptachinski RJ, Venkataramanan R, Burckart GJ, Hakala TR, Rosenthal JT, et al. Cyclosporine: high dose steroid interaction in renal transplant recipients; assessment by HPLC. Transplantation Proceedings 19: 1728\u20131729, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR175","first-page":"419","volume":"2","author":"LC Racusen","year":"1985","unstructured":"Racusen LC, McGraw DJ, Solez K. Cyclosporin nephrotoxicity: effect of clonidine and frusemide. Monographs in Applied Toxicology 2: 419\u2013427, 1985","journal-title":"Monographs in Applied Toxicology"},{"key":"BF03259936_CR176","first-page":"1820","volume":"19","author":"AEG Raine","year":"1987","unstructured":"Raine AEG, Carter R, Mann JI, Chapman JR, Morris PJ. Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression. Transplantation Proceedings 19: 1820\u20131821, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR177","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0022-1759(87)90180-3","volume":"100","author":"LM Reik","year":"1987","unstructured":"Reik LM, Maines SL, Ryan DE, Levin W, Bondiera S, et al. A simple non-chromatographic purification procedure for monoclonal antibodies against cytochrome P-450 isoenzymes. Journal of Immunological Methods 100: 123\u2013130, 1987","journal-title":"Journal of Immunological Methods"},{"key":"BF03259936_CR178","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(87)90595-2","volume":"1","author":"VM Reznik","year":"1987","unstructured":"Reznik VM, Jones KL, Durham BL, Mendoza SA. Changes in facial appearance during cyclosporin treatment. Lancet 1: 1405\u20131414, 1987","journal-title":"Lancet"},{"key":"BF03259936_CR179","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(84)92352-3","volume":"1","author":"O Ringden","year":"1984","unstructured":"Ringden O. Nephrotoxicity by co-trimoxazole and cyclosporin in transplanted patients. Lancet 1: 1016\u20131017, 1984","journal-title":"Lancet"},{"key":"BF03259936_CR180","first-page":"2403","volume":"15","author":"WT Robinson","year":"1983","unstructured":"Robinson WT, Schran HF, Barry EP. Methods to measure cyclosporine levels: high pressure liquid chromatography, radioimmunoassay and correlation. Transplantation Proceedings 15 (4, Suppl. 1): 2403\u20132408, 1983","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR181","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/bmj.288.6428.1417","volume":"288","author":"S Robson","year":"1984","unstructured":"Robson S, Neuberger J, Alexander G, Williams R. Cyclosporine A nephrotoxicity related to changes in haemoglobin concentration. British Medical Journal 288: 1417\u20131418, 1984","journal-title":"British Medical Journal"},{"key":"BF03259936_CR182","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/clinchem\/31.3.410","volume":"31","author":"TG Rosano","year":"1985","unstructured":"Rosano TG. Effect of haematocrit on cyclosporine in whole blood and plasma of renal transplant patients. Clinical Chemistry 31: 410\u2013412, 1985","journal-title":"Clinical Chemistry"},{"key":"BF03259936_CR183","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00007890-198609000-00007","volume":"42","author":"TG Rosano","year":"1986","unstructured":"Rosano TG, Freed BM, Cerilli J, Lembert N. Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients. Transplantation 42: 262\u2013266, 1986a","journal-title":"Transplantation"},{"issue":"5","key":"BF03259936_CR184","first-page":"35","volume":"18","author":"TG Rosano","year":"1986","unstructured":"Rosano TG, Freed BM, Pell MA, Lempert N. Cyclosporine metabolites in human blood and renal tissue. Transplantation Proceedings 18 (Suppl. 5): 35\u201340, 1986b","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR185","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0140-6736(86)90867-6","volume":"1","author":"WB Ross","year":"1986","unstructured":"Ross WB, Roberts D, Griffin PJA, Salaman JR. Cyclosporin interaction with danazol and norethisterone. Lancet 1: 330, 1986","journal-title":"Lancet"},{"key":"BF03259936_CR186","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1212\/WNL.37.6.1072","volume":"37","author":"AM Rubin","year":"1987","unstructured":"Rubin AM, Kang H. Cerebral blindness and encephalopathy with cyclosporin A toxicity. Neurology 37: 1072\u20131076, 1987","journal-title":"Neurology"},{"key":"BF03259936_CR187","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0006-291X(84)90762-9","volume":"121","author":"D Russell","year":"1984","unstructured":"Russell D, Matrisian L, Kibler R, Larson D, Poulos B, et al. Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochemical and Biophysical Research Communications 121: 899\u2013906, 1984","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"5","key":"BF03259936_CR188","first-page":"41","volume":"18","author":"B Ryffel","year":"1986","unstructured":"Ryffel B, Hiestand P, Foxwell B, Donatsch P, Boelsterli HJ, et al. Nephrotoxic and immunosuppressive potentials of cyclosporine metabolites in rats. Transplantation Proceedings 18 (Suppl. 5): 41\u201345, 1986","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR189","first-page":"329","volume":"100","author":"RE Schlanger","year":"1986","unstructured":"Schlanger RE, Henry ML, Sommer BG, Ferguson RM. Identification and treatment of cyclosporine-associated allograft thrombosis. Surgery 100: 329\u2013333, 1986","journal-title":"Surgery"},{"key":"BF03259936_CR190","first-page":"436","volume":"38","author":"M Schmitz-Schumann","year":"1986","unstructured":"Schmitz-Schumann M. Interim report of clinical studies presented at the international symposium on ciclosporin in autoimmune diseases, Basel, March 18\u201320, 1985. Progress in Allergy 38: 436\u2013446, 1986","journal-title":"Progress in Allergy"},{"key":"BF03259936_CR191","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00007890-198603000-00028","volume":"41","author":"TJ Schroeder","year":"1986","unstructured":"Schroeder TJ, Wadhwa NK, Pesce AJ, First MR. An acute overdose of cyclosporin. Transplantation 41: 406\u2013409, 1986","journal-title":"Transplantation"},{"key":"BF03259936_CR192","first-page":"S117","volume":"25","author":"DE Schwass","year":"1986","unstructured":"Schwass DE, Sasaki AW, Houghton DC, Benner KE, Bennett WM. Effect of phenobarbital and cimetidine on experimental cyclosporine nephrotoxicity: preliminary observations. Clinical Nephrology 25 (Suppl. 1): S117\u2013S120, 1986","journal-title":"Clinical Nephrology"},{"issue":"16","key":"BF03259936_CR193","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1042\/cs072048Pb","volume":"72","author":"JP Scott","year":"1987","unstructured":"Scott JP, Higenbottam TW, Cory-Pearse R, English TAH, Wall-work J. Cyclosporine and exercise induced hypertension. Clinical Science 72 (Suppl. 16): 48\u201349, 1987a","journal-title":"Clinical Science"},{"key":"BF03259936_CR194","first-page":"591","volume":"19","author":"JP Scott","year":"1987","unstructured":"Scott JP, Nunez D, Hay IFC, Higenbottam TW, Evans DB, et al. Exercise-induced hypertension in normotensive renal transplant recipients receiving cyclosporine A. Transplantation Proceedings 19: 591\u2013592, 1987b","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR195","first-page":"608","volume":"19","author":"JP Scott","year":"1987","unstructured":"Scott JP, Nunez D, Reardon D, Luddington R, Folawski J, et al. Effect of cyclosporine on platelet aggregation in renal transplant recipients. Transplantation Proceedings 19: 608\u2013609, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR196","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/bmj.289.6455.1347","volume":"289","author":"D Shah","year":"1984","unstructured":"Shah D, Rylance PB, Rogerson ME, Bewick M, Parsons V. Generalised epileptic fits in renal transplant recipients given cyclosporin A. British Medical Journal 289: 1347\u20131348, 1984","journal-title":"British Medical Journal"},{"key":"BF03259936_CR197","first-page":"82","volume-title":"Effect of cyclosporin-A on prostacyclin production by human endo-thelial cells. Abstract","author":"WV Sharp","year":"1987","unstructured":"Sharp WV, Todd R, Pippert MS, Igel BJ, Schmidt SP. Effect of cyclosporin-A on prostacyclin production by human endo-thelial cells. Abstract p. 82. International Organ Transplant Forum, Pittsburgh, 1987"},{"key":"BF03259936_CR198","first-page":"2214","volume":"19","author":"AGR Sheil","year":"1987","unstructured":"Sheil AGR, Flavel S, Disry APS, Mathew TU, Hall BM. Cancer incidence in renal transplant patients treated with azathioprine or cyclosporine. Transplantation Proceedings 19: 2214\u20132216, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR199","first-page":"1755","volume":"19","author":"B Sido","year":"1987","unstructured":"Sido B, Hammer C, Mraz W, Krombach F. Nephroprotective effect of imipenem\/cilastatin in reducing cyclosporine toxicity. Transplantation Proceedings 19: 1755\u20131758, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR200","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(82)90124-6","volume":"2","author":"H Siegl","year":"1982","unstructured":"Siegl H, Ryffel B. Effect of cyclosporin on renin angiotensin-aldosterone system. Lancet 2: 1274, 1982","journal-title":"Lancet"},{"key":"BF03259936_CR201","first-page":"917","volume":"34","author":"RE Smith","year":"1986","unstructured":"Smith RE, Ash RC. Coagulation defects in cyclosporin treated allogenic bone marrow transplant patients. Clinical Research 34: 917A, 1986","journal-title":"Clinical Research"},{"key":"BF03259936_CR202","first-page":"1285","volume":"18","author":"BG Sommer","year":"1986","unstructured":"Sommer BG, Henry ML, Ferguson RM. Obliterative arteriopathy following cyclosporine therapy. Transplantation Proceedings 18: 1285\u20131286, 1986","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR203","first-page":"245","volume":"25","author":"RAK Stahl","year":"1986","unstructured":"Stahl RAK, Kanz L, Maier B, Schollmeyer P. Hyperchloremic metabolic acidosis with high serum potassium in renal transplant recipients: a cydosporine A associated side effect. Clinical Nephrology 25: 245\u2013248, 1986","journal-title":"Clinical Nephrology"},{"key":"BF03259936_CR204","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/01.HYP.9.6_Pt_2.III31","volume":"9","author":"N Stern","year":"1987","unstructured":"Stern N, Lustig S, Petrasek D, Jensen G, Eggena P, et al. Cyclosporin-A induced hyperreninaemic hypoaldosteronism: a model of adrenal resistance to angiotensin II. Hypertension 9 (Suppl.): 31\u201335, 1987","journal-title":"Hypertension"},{"key":"BF03259936_CR205","first-page":"1393","volume":"19","author":"T Strezelecki","year":"1987","unstructured":"Strezelecki T, Khaudi RB, Kumar S, Menan M. In vitroeffects of cyclosporine on function of rat kidney mitochondria. Transplantation Proceedings 19: 1393\u20131394, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR206","first-page":"315","volume":"101","author":"B Sumpio","year":"1987","unstructured":"Sumpio B, Baue AE, Chaudry IH. Treatment with verapamil and adenosine-MgCh reduces cyclosporine nephrotoxicity. Surgery 101: 315\u2013322, 1987","journal-title":"Surgery"},{"key":"BF03259936_CR207","first-page":"1398","volume":"19","author":"S Suzuki","year":"1987","unstructured":"Suzuki S, Oka T, Ohkuma S, Kuriyama K. Nephrotoxicity of cyclosporine and its prevention by concomitant administration of prednisolone: biochemical and morphological analysis. Transplantation Proceedings 19 (1, pt 2): 1398\u20131402, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR208","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/clinchem\/33.7.1269","volume":"33","author":"Task Force on Cyclosporine Monitoring","year":"1987","unstructured":"Task Force on Cyclosporine Monitoring. Critical issues in cyclosporine monitoring. Clinical Chemistry 33: 1269\u20131288, 1987","journal-title":"Clinical Chemistry"},{"key":"BF03259936_CR209","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0002-9343(83)91031-8","volume":"74","author":"SC Textor","year":"1983","unstructured":"Textor SC, Gerhardt GN, Bravo EL, Tarazi RC, Fouad FM, et al. Membranous glomerulopathy associated with captopril therapy. American Journal of Medicine 74: 705\u2013712, 1983","journal-title":"American Journal of Medicine"},{"key":"BF03259936_CR210","first-page":"S155","volume":"25","author":"G Thiel","year":"1986","unstructured":"Thiel G, Brunner FP, Hermle M, Stahl RAK, Mihatsch MJ. Effect of cyclosporine A on ischemic renal failure in the rat. Clinical Nephrology 25 (Suppl. 1): S155\u2013161, 1986","journal-title":"Clinical Nephrology"},{"key":"BF03259936_CR211","first-page":"S40","volume":"25","author":"G Thiel","year":"1986","unstructured":"Thiel G, Hermle M, Brunner FP. Acutely impaired renal function during intravenous administration of cyclosporine A: a cremophor side-effect. Nephrology 25 (Suppl. 1): S40\u2013S42, 1986","journal-title":"Nephrology"},{"key":"BF03259936_CR212","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/BF01978803","volume":"11","author":"K Thommen-Scott","year":"1981","unstructured":"Thommen-Scott K. Antimalarial activity of cyclosporin A. Agents and Actions 11: 770\u2013773, 1981","journal-title":"Agents and Actions"},{"key":"BF03259936_CR213","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(84)91556-3","volume":"2","author":"CB Thompson","year":"1984","unstructured":"Thompson CB, June CH, Sullivan KM, Thomas ED. Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet 2: 1116\u20131120, 1984","journal-title":"Lancet"},{"key":"BF03259936_CR214","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00007890-198308000-00021","volume":"36","author":"JF Thompson","year":"1983","unstructured":"Thompson JF, Chalmers DH, Hunnisett AG, Wood RF, Morris PJ. Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporine. Transplantation 36: 204\u2013206, 1983","journal-title":"Transplantation"},{"key":"BF03259936_CR215","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0167-5273(86)90181-6","volume":"11","author":"ME Thompson","year":"1986","unstructured":"Thompson ME, Sharpiro AP, Johnsen A-M, Itzkoff JM, Hardesty RL, et al. The contrasting effects of cyclosporine-A and azathioprine on arterial blood pressure and renal function following cardiac transplantation. International Journal of Cardiology 11: 219\u2013229, 1986","journal-title":"International Journal of Cardiology"},{"key":"BF03259936_CR216","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/028418518702800112","volume":"28","author":"HS Thomsen","year":"1987","unstructured":"Thomsen HS, Munck O. Use of 99Tcm radionucleotides to show nephrotoxicity of cyclosporin A in transplanted kidneys. Acta Radiologica 28: 59\u201362, 1987","journal-title":"Acta Radiologica"},{"key":"BF03259936_CR217","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(85)91166-3","volume":"1","author":"DJ Tiller","year":"1985","unstructured":"Tiller DJ, Hall BM, Horvarth JS, Duggin GG, Thompson JF, et al. Gout and hyperuricaemia in patients on cyclosporin and diuretics. Lancet 1: 453, 1985","journal-title":"Lancet"},{"key":"BF03259936_CR218","first-page":"386","volume-title":"Cyclosporine: biological activity and clinical applications","author":"J Traeger","year":"1984","unstructured":"Traeger J, Dubernard JM, Bosi E, Gelet A, El Yafi S, et al. Cyclosporine in clinical pancreatic transplantation. In Kahan (Ed.) Cyclosporine: biological activity and clinical applications, pp. 386\u2013389, Grune & Stratton, Orlando, Florida, 1984"},{"issue":"5","key":"BF03259936_CR219","first-page":"16","volume":"18","author":"G Tufveson","year":"1986","unstructured":"Tufveson G, Odlind B, Sjoberg A, Gabrielsson J, Lindstrom B, et al. A longitudinal study of the pharmacokinetics of cyclosporine A and in vitrolymphocyte responses in renal transplant patients. Transplantation Proceedings 18 (Suppl. 5): 16\u201324, 1986","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR220","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.4049\/jimmunol.137.11.3620","volume":"137","author":"K Uyemura","year":"1986","unstructured":"Uyemura K, Dixon JFP, Wong L, Rea TH, Modlin RL. Effect of cyclosporine A in erythema nodosum leprosum. Journal of Immunology 137: 3620\u20133623, 1986","journal-title":"Journal of Immunology"},{"key":"BF03259936_CR221","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0009-8981(85)90212-8","volume":"147","author":"JWO Berg Van der","year":"1985","unstructured":"Van der Berg JWO, Verhoef ML, de Boer AJH, Schalm SW. Cyclosporin A assay: conditions for sampling and processing of blood. Clinica Chimica Acta 147: 291\u2013297, 1985","journal-title":"Clinica Chimica Acta"},{"key":"BF03259936_CR222","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/ard.45.9.726","volume":"45","author":"AWAM Rijthoven Van","year":"1986","unstructured":"Van Rijthoven AWAM, Dijkmans BA, The HSG, Hermans J, Montnorb ZL, et al. Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicenter study. Annals of the Rheumatic Diseases 45: 726\u2013731, 1986","journal-title":"Annals of the Rheumatic Diseases"},{"key":"BF03259936_CR223","first-page":"1556","volume":"18","author":"R Scilfgaarde Van","year":"1986","unstructured":"Van Scilfgaarde R, Van der Berg MPM, Van Suylichem PTR, Gooszen HG, Frolich M. Reversible suppression of canine beta cell function by cyclosporine A is dose dependent. Transplantation Proceedings 18: 1556\u20131557, 1986","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR224","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(85)91610-1","volume":"1","author":"Y Vanrenterghem","year":"1985","unstructured":"Vanrenterghem Y, Roels L, Lerut T, Gruwez J, Gresele P, et al. Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet 1: 999\u20131002, 1985","journal-title":"Lancet"},{"key":"BF03259936_CR225","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(85)92052-5","volume":"1","author":"T Velu","year":"1985","unstructured":"Velu T, Debusscher L, Stryckmans PA. Cyclosporin-associated fatal convulsions. Lancet 1: 219, 1985","journal-title":"Lancet"},{"key":"BF03259936_CR226","first-page":"286","volume":"17","author":"R Venkataramanan","year":"1985","unstructured":"Venkataramanan R, Starzl TE, Yang S, Burckart GJ, Ptachinski RJ, et al. Biliary excretion of cyclosporine in liver transplant patients. Transplantation Proceedings 17: 286\u2013289, 1985","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR227","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00007890-198707000-00033","volume":"44","author":"P Vereerstraeten","year":"1987","unstructured":"Vereerstraeten P, Thiry P, Kinnaert P, Toussaint C. Influence of erythromycin on cyclosporine pharmacokinetics. Transplantation 44: 155\u2013156, 1987","journal-title":"Transplantation"},{"key":"BF03259936_CR228","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00320893","volume":"53","author":"C Verhagen","year":"1986","unstructured":"Verhagen C, de Pauw BE, de Witte T, Holdrinet RSG, Janssen JTP, et al. Ceftazidime does not enhance cyclosporin-A nephrotoxicity in febrile bone marrow transplant patients Blut 53: 333\u2013339, 1986","journal-title":"Blut"},{"key":"BF03259936_CR229","first-page":"S18","volume":"25","author":"GA Verpooten","year":"1986","unstructured":"Verpooten GA, Wybo I, Pattyn VM, Hendirx PG, Giuliano RA, et al. Cyclosporine nephrotoxicity: comparative cytochemical study of rat kidney and human allograft biopsies. Clinical Nephrology 25 (Suppl. 1): S18\u2013S22, 1986","journal-title":"Clinical Nephrology"},{"issue":"1","key":"BF03259936_CR230","first-page":"1353","volume":"19","author":"K Wagner","year":"1987","unstructured":"Wagner K, Neumayer H-H. Influence of the calcium antagonist diltiazem on delayed graft function in cadaveric kidney transplantation: results of a 6-month follow-up. Transplantation Proceedings 19(1): 1353\u20131357, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR231","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/106002808501900106","volume":"19","author":"PE Wallemaq","year":"1985","unstructured":"Wallemaq PE, Lesne ML. Accidental massive IV administration of cyclosporin in man. Drug Intelligence and Clinical Pharmacology 19: 29\u201330, 1985","journal-title":"Drug Intelligence and Clinical Pharmacology"},{"key":"BF03259936_CR232","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(83)91675-6","volume":"1","author":"J Wallwork","year":"1983","unstructured":"Wallwork J, Macgregor CG, Wells FC, Cory-Pearce R, English TA. Cyclosporin and intravenous sulphadimidine and trimethoprim therapy. Lancet 1: 366\u2013367, 1983","journal-title":"Lancet"},{"key":"BF03259936_CR233","first-page":"1161","volume":"19","author":"FW Wamboldt","year":"1984","unstructured":"Wamboldt FW, Weiler SJ, Kalin NH. Cyclospcrine-associated mania. Biological Psychology 19: 1161\u20131162, 1984","journal-title":"Biological Psychology"},{"key":"BF03259936_CR234","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0006-2952(84)90516-1","volume":"33","author":"PH Whiting","year":"1984","unstructured":"Whiting PH, Cunningham C, Thomson AW, Simpson JG. Enhancement of high-dose cyclosporine-A toxicity by frusemide. Biochemical Pharmacology 33: 1075\u20131079, 1984","journal-title":"Biochemical Pharmacology"},{"key":"BF03259936_CR235","first-page":"554","volume":"63","author":"PH Whiting","year":"1982","unstructured":"Whiting PH, Simpson JG. The toxic effects of combined administration of cyclosporin A and gentamycin. British Journal of Experimental Pathology 63: 554\u2013561, 1982","journal-title":"British Journal of Experimental Pathology"},{"issue":"4","key":"BF03259936_CR236","first-page":"2702","volume":"15","author":"PH Whiting","year":"1983","unstructured":"Whiting PH, Simpson JG, Thomson AW. Nephrotoxicity of cyclosporine in combination with aminoglycoside antibiotics. Transplantation Proceedings 15 (Suppl. 4): 2702\u20132707, 1983a","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR237","first-page":"134","volume":"17","author":"PH Whiting","year":"1985","unstructured":"Whiting PH, Thomson AW, Simpson JG. Cyclosporine: toxicity, metabolism and drug interactions-implications from animal studies. Transplantation Proceedings 17 (4, Suppl. 1): 134\u2013144, 1985","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR238","first-page":"693","volume":"64","author":"PH Whiting","year":"1983","unstructured":"Whiting PH, Thomson AW, Simpson JG. Renal and hepatic function in rats treated with cyclosporin A in combination with gentamycin of cephalosporin antibiotics. British Journal of Experimental Pathology 64: 693\u2013701, 1983","journal-title":"British Journal of Experimental Pathology"},{"key":"BF03259936_CR239","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00007890-198501000-00022","volume":"39","author":"H Wilczek","year":"1985","unstructured":"Wilczek H, Ringden O, Tyden G. Cyclosporine-associated central nervous system toxicity after renal transplantation. Transplantation 39: 110, 1985","journal-title":"Transplantation"},{"key":"BF03259936_CR240","first-page":"1785","volume":"19","author":"EPM Williamson","year":"1987","unstructured":"Williamson EPM, Millar RJ, Criddle RA, Sells RA. The differentiation of acute renal allograft rejection and cyclosporine nephrotoxicity by simple urine cytology. Transplantation Proceedings 19: 1785\u20131786, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR241","first-page":"370","volume-title":"Cyclosporine: biological activity and clinical applications","author":"K Wonigeit","year":"1984","unstructured":"Wonigeit K, Brolsch C, Neuhaus P, Burdelski M, Schmidt E, et al. Special aspects of immunosuppression with cyclosporine in liver transplantation. In Kahan (Ed.) Cyclosporine: biological activity and clinical applications, pp. 370\u2013375, Grune & Stratton, Orlando, Florida, 1984"},{"key":"BF03259936_CR242","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00007890-198705000-00022","volume":"43","author":"H Xue","year":"1987","unstructured":"Xue H, Bukoski RD, McCarron DA. Induction of contraction in isolated rat aorta by cyclosporine. Transplantation 43: 715\u2013717, 1987","journal-title":"Transplantation"},{"key":"BF03259936_CR243","first-page":"1548","volume":"18","author":"T Yagisawa","year":"1986","unstructured":"Yagisawa T, Takahashi K, Teraoka S, Toma H, Agishi T, et al. Deterioration in glucose metabolism in cyclosporine-treated kidney transplant recipients and rats. Transplantation Proceedings 18: 1548\u20131551, 1986","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR244","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood.V64.6.1277.1277","volume":"64","author":"GC Yee","year":"1984","unstructured":"Yee GC, Kennedy MS, Storb R, Thomas ED. Effect of hepatic dysfunction on oral cyclosporine pharmacokinetics in marrow transplant patients. Blood 64: 1277\u20131279, 1984","journal-title":"Blood"},{"key":"BF03259936_CR245","first-page":"1704","volume":"19","author":"GC Yee","year":"1987","unstructured":"Yee GC, Lennon TP, Gmur DJ, Kennedy MS, Deeg HJ. Effect of age on cyclosporine pharmacokinetics in marrow transplant recipients. Transplantation Proceedings 19: 1704\u20131705, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR246","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/clpt.1986.204","volume":"40","author":"GC Yee","year":"1986","unstructured":"Yee GC, Lennon TP, Gmur DJ, Kennedy MS, Deeg HJ. Agedependent cyclosporine: pharmacokinetics in marrow transplant recipients. Clinical Pharmacology and Therapeutics 40: 438\u2013443, 1986","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259936_CR247","first-page":"1199","volume":"19","author":"N Yoshimura","year":"1987","unstructured":"Yoshimura N, Oka T, Ohmori Y, Aikawa I, Fukuda M, et al. Influence of in vivocyclosporine on interleukin production in kidney transplant recipients. Transplantation Proceedings 19: 1199\u20131201, 1987","journal-title":"Transplantation Proceedings"},{"key":"BF03259936_CR248","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2133.1987.tb05912.x","volume":"116","author":"H Zachariae","year":"1987","unstructured":"Zachariae H, Zachariae E. Cyclosporin-A in systemic sclerosis. British Journal of Dermatology 116: 741\u2013742, 1987","journal-title":"British Journal of Dermatology"},{"key":"BF03259936_CR249","first-page":"455","volume":"55","author":"C Zoja","year":"1986","unstructured":"Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, et al. Cyclosporin-induced endothelial injury. Laboratory Investigations 55: 455\u2013462, 1986","journal-title":"Laboratory Investigations"},{"key":"BF03259936_CR250","doi-asserted-by":"crossref","first-page":"843","DOI":"10.7326\/0003-4819-106-6-843","volume":"106","author":"M Zwitter","year":"1987","unstructured":"Zwitter M, Drinovec J, Dubravcic M, Vodnik A, Petric-Grabnor J, et al. Cyclosporine may alleviate B symptoms and induce a remission of heavily pretreated Hodgkin\u2019s disease: a preliminary report. Annals of Internal Medicine 106: 843, 1987","journal-title":"Annals of Internal Medicine"}],"container-title":["Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259936.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03259936\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:29:31Z","timestamp":1745368171000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03259936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,4]]},"references-count":250,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1988,4]]}},"alternative-id":["BF03259936"],"URL":"https:\/\/doi.org\/10.1007\/bf03259936","relation":{},"ISSN":["0112-5966"],"issn-type":[{"type":"print","value":"0112-5966"}],"subject":[],"published":{"date-parts":[[1988,4]]}}}